Review: could Rituxan cause Capillary leak syndrome?
This is a review of Capillary leak syndrome by studying 10,172 people who take Rituxan. We analyze: the time on Rituxan when people have Capillary leak syndrome, gender and age of these people, the severity of Capillary leak syndrome, how they recovered, and common conditions and drugs used besides Rituxan. The review is created by eHealthMe based on reports from FDA and social media, and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. We use data reported since 1977 till to date. All studies are personalized to gender and age. Start now >>>
Rituxan (latest outcomes from 10,284 users) has active ingredients of rituximab. It is often used in rheumatoid arthritis, non-hodgkin's lymphoma. Commonly reported side effects of Rituxan include fever, agranulocytosis, neutropenia aggravated, hypotension, febrile neutropenia.
Capillary leak syndrome
Capillary leak syndrome (capillary leaks plasma) (latest reports from 4,586 patients) has been reported by people with acute myeloid leukaemia, breast cancer, pain, multiple myeloma, pancreatic carcinoma.
On Mar, 4, 2014: 9,885 people reported to have side effects when taking Rituxan. Among them, 5 people (0.05%) have Capillary Leak Syndrome.
Time on Rituxan when people have Capillary leak syndrome * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Capillary leak syndrome||100.00%||0.00%||0.00%||0.00%||0.00%||0.00%||0.00% |
Gender of people who have Capillary leak syndrome when taking Rituxan * :
|Capillary leak syndrome||77.78%||22.22% |
Age of people who have Capillary leak syndrome when taking Rituxan * :
|Capillary leak syndrome||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||100.00% |
Severity of Capillary leak syndrome when taking Rituxan ** :
How people recovered from Capillary leak syndrome ** :
Top conditions involved for these people * :
- Lymphoma (5 people, 100.00%)
- Thrombocytopenia (4 people, 80.00%)
Top co-used drugs for these people * :
- Fludarabine phosphate (4 people, 80.00%)
- Verapamil (4 people, 80.00%)
- Xalatan (4 people, 80.00%)
- Ambien (4 people, 80.00%)
- Cozaar (4 people, 80.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Rituxan, Capillary leak syndrome
You can also:
On eHealthMe, Rituxan (rituximab) is often used for rheumatoid arthritis. Find out below the conditions Rituxan is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Rituxan used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Browse Rituxan side effects from A to Z:
Browse Rituxan drug interactions with drugs from A to Z:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (2 weeks ago):
Peripheral neuropathy began shortly after Rituxan regime for lymphoma.
It has continued for over 12 years
Alleviated a bit by cymbalta
From this study (2 months ago):
Taking Cellcept and prednisone also
From this study (2 months ago):
fevers, complication pain & nauseu management, especially in regard to anxiety
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Rituxan, Capillary leak syndrome
More reviews for: Rituxan, Capillary leak syndrome
Related drug studies for: Rituxan, Capillary leak syndrome
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.